These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35078530)

  • 1. An application of PRECIS-2 to evaluate trial design in a pilot cluster randomised controlled trial of a community-based smoking cessation intervention for women living in disadvantaged areas of Ireland.
    Darker C; Loudon K; O'Connell N; Castello S; Burke E; Vance J; Reynolds C; Buggy A; Dougall N; Williams P; Dobbie F; Bauld L; Hayes CB
    Pilot Feasibility Stud; 2022 Jan; 8(1):19. PubMed ID: 35078530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. We Can Quit2 (WCQ2): a community-based intervention on smoking cessation for women living in disadvantaged areas of Ireland-study protocol for a pilot cluster randomised controlled trial.
    Hayes C; Ciblis A; Darker C; Dougall N; Vance J; O'Connell N; Dobbie F; Loudon K; Burke E; Devane D; Bauld L
    Pilot Feasibility Stud; 2019; 5():138. PubMed ID: 31788324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peer-Delivery of a Gender-Specific Smoking Cessation Intervention for Women Living in Disadvantaged Communities in Ireland We Can Quit2 (WCQ2)-A Pilot Cluster Randomized Controlled Trial.
    Hayes CB; Patterson J; Castello S; Burke E; O'Connell N; Darker CD; Bauld L; Vance J; Ciblis A; Dobbie F; Loudon K; Devane D; Dougall N
    Nicotine Tob Res; 2022 Mar; 24(4):564-573. PubMed ID: 34939119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot cluster randomised controlled trial of a peer-delivered outreach community-based smoking cessation intervention for women living in disadvantaged communities in Ireland.
    Hayes CB; Patterson J; Castello S; Burke E; O'Connell N; Darker C; Vance J; Bauld L; Dobbie F; Loudon K; Devane D; Dougall N
    Rural Remote Health; 2023 Jan; 23(1):8163. PubMed ID: 36802719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A process evaluation of 'We Can Quit': a community-based smoking cessation intervention targeting women from areas of socio-disadvantage in Ireland.
    Darker CD; Burke E; Castello S; O'Sullivan K; O'Connell N; Vance J; Reynolds C; Buggy A; Dougall N; Loudon K; Williams P; Dobbie F; Bauld L; Hayes CB
    BMC Public Health; 2022 Aug; 22(1):1528. PubMed ID: 35948970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dynamic application of PRECIS-2 to evaluate implementation in a pragmatic, cluster randomized clinical trial in two nursing home systems.
    Palmer JA; Mor V; Volandes AE; McCreedy E; Loomer L; Carter P; Dvorchak F; Mitchell SL
    Trials; 2018 Aug; 19(1):453. PubMed ID: 30134976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot randomised trial to assess the methods and procedures for evaluating the clinical effectiveness and cost-effectiveness of Exercise Assisted Reduction then Stop (EARS) among disadvantaged smokers.
    Taylor AH; Thompson TP; Greaves CJ; Taylor RS; Green C; Warren FC; Kandiyali R; Aveyard P; Ayres R; Byng R; Campbell JL; Ussher MH; Michie S; West R
    Health Technol Assess; 2014 Jan; 18(4):1-324. PubMed ID: 24433837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking Cessation Intervention for severe Mental Ill Health Trial (SCIMITAR): a pilot randomised control trial of the clinical effectiveness and cost-effectiveness of a bespoke smoking cessation service.
    Peckham E; Man MS; Mitchell N; Li J; Becque T; Knowles S; Bradshaw T; Planner C; Parrott S; Michie S; Shepherd C; Gilbody S
    Health Technol Assess; 2015 Mar; 19(25):1-148, v-vi. PubMed ID: 25827850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating pragmatic and implementation science randomized clinical trial approaches: a PRagmatic Explanatory Continuum Indicator Summary-2 (PRECIS-2) analysis.
    Zatzick D; Palinkas L; Chambers DA; Whiteside L; Moloney K; Engstrom A; Prater L; Russo J; Wang J; Abu K; Iles-Shih M; Bulger E
    Trials; 2023 Apr; 24(1):288. PubMed ID: 37085877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains.
    Lipman PD; Loudon K; Dluzak L; Moloney R; Messner D; Stoney CM
    Trials; 2017 Nov; 18(1):532. PubMed ID: 29126437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of PRECIS ratings in the National Institutes of Health (NIH) Health Care Systems Research Collaboratory.
    Johnson KE; Neta G; Dember LM; Coronado GD; Suls J; Chambers DA; Rundell S; Smith DH; Liu B; Taplin S; Stoney CM; Farrell MM; Glasgow RE
    Trials; 2016 Jan; 17():32. PubMed ID: 26772801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing provider-focused implementation trials with purpose and intent: introducing the PRECIS-2-PS tool.
    Norton WE; Loudon K; Chambers DA; Zwarenstein M
    Implement Sci; 2021 Jan; 16(1):7. PubMed ID: 33413489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How pragmatic or explanatory is the randomized, controlled trial? The application and enhancement of the PRECIS tool to the evaluation of a smoking cessation trial.
    Selby P; Brosky G; Oh PI; Raymond V; Ranger S
    BMC Med Res Methodol; 2012 Jul; 12():101. PubMed ID: 22824225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facing the Realities of Pragmatic Design Choices in Environmental Health Studies: Experiences from the Household Air Pollution Intervention Network Trial.
    Checkley W; Hossen S; Rosa G; Thompson LM; McCracken JP; Diaz-Artiga A; Balakrishnan K; Simkovich SM; Underhill LJ; Nicolaou L; Hartinger SM; Davila-Roman VG; Kirby MA; Clasen TF; Rosenthal J; Peel JL; On Behalf Of Household Air Pollution Intervention Network Hapin Investigators
    Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bespoke smoking cessation service compared with treatment as usual for people with severe mental ill health: the SCIMITAR+ RCT.
    Peckham E; Arundel C; Bailey D; Crosland S; Fairhurst C; Heron P; Hewitt C; Li J; Parrott S; Bradshaw T; Horspool M; Hughes E; Hughes T; Ker S; Leahy M; McCloud T; Osborn D; Reilly J; Steare T; Ballantyne E; Bidwell P; Bonner S; Brennan D; Callen T; Carey A; Colbeck C; Coton D; Donaldson E; Evans K; Herlihy H; Khan W; Nyathi L; Nyamadzawo E; Oldknow H; Phiri P; Rathod S; Rea J; Romain-Hooper CB; Smith K; Stribling A; Vickers C; Gilbody S
    Health Technol Assess; 2019 Sep; 23(50):1-116. PubMed ID: 31549622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced psychological care in cardiac rehabilitation services for patients with new-onset depression: the CADENCE feasibility study and pilot RCT.
    Richards SH; Campbell JL; Dickens C; Anderson R; Gandhi M; Gibson A; Kessler D; Knight L; Kuyken W; Richards DA; Taylor RS; Turner K; Ukoumunne OC; Davey A; Warren FC; Winder RE; Wright CA
    Health Technol Assess; 2018 May; 22(30):1-220. PubMed ID: 29856312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRECIS-2 analysis of pragmatic acupuncture trials: a systematic review.
    Lim J; Lee H; Kim YS
    BMC Complement Med Ther; 2024 May; 24(1):181. PubMed ID: 38702632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How pragmatic are the randomised trials used in recommendations for control of glycosylated haemoglobin levels in type 2 diabetic patients in general practice: an application of the PRECIS II tool.
    Ettori-Ajasse I; Tatin E; Forbes G; Eldridge S; Dibao-Dina C
    Trials; 2020 Mar; 21(1):281. PubMed ID: 32188470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot and feasibility studies for pragmatic trials have unique considerations and areas of uncertainty.
    Chan CL; Taljaard M; Lancaster GA; Brehaut JC; Eldridge SM
    J Clin Epidemiol; 2021 Oct; 138():102-114. PubMed ID: 34229091
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.